Lykos Therapeutics logo

Lykos Therapeutics

Dedicated to transforming mental healthcare

120 employees · est. 2014 · San Jose, United States

VS
Mindbloom logo

Mindbloom

At-Home Psychedelic Therapy

163 employees · est. 2018 · New York, United States

Lykos Therapeutics is the older company (2014 vs 2018).

Side-by-Side Comparison

Lykos Therapeutics Mindbloom
Founded
2014 older 2018
Headquarters
San Jose, United States New York, United States
Employees
120 163
Industry
Health Care, Marketing Health Care, Health and Wellness
Funding Stage
Series A Unknown
Total Funding
$100.00M $3.20M
Funding Rounds
2 4
Services
Not tracked yet ketamine therapy sessions, psychiatric evaluations, personalized treatment plans, mental health coaching, group integration circles
Target Customers
Not tracked yet individuals with anxiety, individuals with depression, individuals with PTSD, mental health patients, adults seeking alternative therapy
Taxonomy
Mental Health Treatment, Psychedelic Therapies, Public Benefit Corporation, Drug Development, Clinical Research, PTSD Research, Anxiety Research, Social Anxiety Research, Medical Research, Schedule I Research, Psychedelic Research, Plant Medicine, Therapeutic Approaches, Innovative Medicines, Revolutionizing Mental Health At-Home Psychedelic Therapy, Ketamine Therapy, Mental Health, Digital Health, Telemedicine, Remote-First Company, Psychedelic Medicine, Guided Integration, Science-Backed Medicine, Psychedelic Therapy, Consumer Healthcare, Mental Health Breakthroughs
Website
lykospbc.com mindbloom.com
Lykos Therapeutics logo

About Lykos Therapeutics

Lykos Therapeutics (formerly MAPS PBC) is a healthcare startup dedicated to transforming mental healthcare. Founded in 2014 and headquartered in the United States, the company's slogan reflects its commitment to driving change in the industry. With a mission to apply evidence-based research, Lykos T...

Mindbloom logo

About Mindbloom

Mindbloom, an innovative leader in the mental health industry, is revolutionizing the way patients can receive care by offering At-Home Psychedelic Therapy. Founded in 2018 and headquartered in the United States, the company specializes in guided at-home ketamine therapy, a cutting-edge approach her...

We will tell you when either one moves

BounceWatch watches Lykos Therapeutics and Mindbloom for new funding, fast hiring, new executives and a change of software vendor. When one happens, we email you the same day.

Watch both — free

Funding, hiring, leadership and stack changes at Lykos Therapeutics and Mindbloom — by email.

Frequently Asked Questions

Lykos Therapeutics — Dedicated to transforming mental healthcare . Mindbloom — At-Home Psychedelic Therapy. Both companies operate in related markets but may differ in funding stage, team size, and product focus.
Lykos Therapeutics has raised $100.00M while Mindbloom has raised $3.20M.
Lykos Therapeutics and Mindbloom operate in overlapping markets and are frequently compared. Track both companies on Bounce Watch to monitor their growth signals in real time.

Compare Lykos Therapeutics with someone else

Start typing a company name or domain.

Compiled from the BounceWatch company index. We last looked at Lykos Therapeutics on 12 Sep 2024, and Mindbloom on 15 Mar 2026. Where a field is blank here, it means we have not recorded it — not that the answer is zero. How we source and date this.

One analytics cookie (Google Analytics). Cookie Policy